Successful long-term replacement therapy with FXIII concentrate (Fibrogammin® P) for severe congenital factor XIII deficiency: a prospective multicentre study

被引：20
作者：
Dreyfus, M. [1 ,2 ]
Barrois, D. [3 ]
Borg, J-Y [4 ]
Claeyssens, S. [5 ]
Torchet, M-F [6 ]
Arnuti, B. [7 ]
Pautard, B. [8 ]
机构：
[1] Hop Bicetre, Serv Hematol Biol, F-94270 Le Kremlin Bicetre, France
[2] AP HP, Fac Med Paris Sud, Paris, France
[3] Cap Sante 49, Angers, France
[4] Hop Charles Nicolle, Hematol Lab, Rouen, France
[5] Hop Purpan, Ctr Reg Hemophiles, Toulouse, France
[6] Hop Necker Enfants Malad, Ctr Traitement Hemophiles, Paris, France
[7] Ctr Hosp Gen, Unite Hemovigilance, Valence, France
[8] Ctr Hosp Univ Nord, Serv Oncohemato Pediat, Ctr Accueil & Traitement Enfants & Adolescents He, Amiens, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷 / 06期
关键词：
RARE COAGULATION DISORDERS; INTRACRANIAL HEMORRHAGE; PHARMACOKINETICS; PROPHYLAXIS; SAFETY; PLASMA;
D O I：
10.1111/j.1538-7836.2011.04281.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1264 / 1266
页数：3
相关论文
共 13 条
  • [1] ABBONDANZO SL, 1988, AM J PEDIAT HEMATOL, V10, P65
  • [2] The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation
    Bolton-Maggs, PHB
    Perry, DJ
    Chalmers, EA
    Parapia, LA
    Wilde, JT
    Williams, MD
    Collins, PW
    Kitchen, S
    Dolan, G
    Mumford, AD
    [J]. HAEMOPHILIA, 2004, 10 (05) : 593 - 628
  • [3] BRACKMANN HH, 1995, THROMB HAEMOSTASIS, V74, P622
  • [4] Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products
    Chandra, S
    Groener, A
    Feldman, F
    [J]. THROMBOSIS RESEARCH, 2002, 105 (05) : 391 - 400
  • [5] Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran
    Eshghi, P.
    Mahjour, S. B.
    Naderi, M.
    Dehbozorgian, J.
    Karimi, M.
    [J]. HAEMOPHILIA, 2010, 16 (02) : 383 - 385
  • [6] Factor XIII deficiency
    Hsieh, L.
    Nugent, D.
    [J]. HAEMOPHILIA, 2008, 14 (06) : 1190 - 1200
  • [7] International Registry on Factor XIII Deficiency: A basis formed mostly on European data
    Ivaskevicius, Vytautas
    Seitz, Rainer
    Kohler, Hans R.
    Schroeder, Verena
    Muszbek, Laszlo
    Ariens, Robert A. S.
    Seifried, Erhard
    Oldenburg, Johannes
    [J]. THROMBOSIS AND HAEMOSTASIS, 2007, 97 (06) : 914 - 921
  • [8] Factor XIII Deficiency
    Karimi, Mehran
    Bereczky, Zsuzsanna
    Cohan, Nader
    Muszbek, Laszlo
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (04) : 426 - 438
  • [9] Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency
    Lovejoy, AE
    Reynolds, TC
    Visich, JE
    Butine, MD
    Young, G
    Belvedere, MA
    Blain, RC
    Pederson, SM
    Ishak, LM
    Nugent, DJ
    [J]. BLOOD, 2006, 108 (01) : 57 - 62
  • [10] Prophylactic therapy with Fibrogammin® P is associated with a decreased incidence of bleeding episodes: a retrospective study
    Lusher, J.
    Pipe, S. W.
    Alexander, S.
    Nugent, D.
    [J]. HAEMOPHILIA, 2010, 16 (02) : 316 - 321
12